| RS2086699971 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis syndrome |
| RS2086712268 |
NPC2
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C2 |
| RS2086712337 |
NPC2
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C2 |
| RS2086712538 |
NPC2
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type C2 |
| RS2086712682 |
NPC2
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C2 |
| RS2086730156 |
PRMT7
|
Health Risk |
Likely pathogenic |
— |
| RS2086763634 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS2086765953 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2086767947 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2086772786 |
PEX16
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS2086777094 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2086778829 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS2086784918 |
PCNT
|
Health Risk |
Pathogenic |
— |
| RS2086784990 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, ATM-related disorder |
| RS2086789644 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2086793763 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2086794191 |
PCNT
|
Health Risk |
Pathogenic |
Microcephalic osteodysplastic primordial dwarfism type II, Microcephalic osteodysplastic primordial dwarfism type II |
| RS2086795898 |
ATM
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2086800136 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2086801267 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2086805219 |
FANCD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group D2, Fanconi anemia |
| RS2086806957 |
FANCD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group D2, Fanconi anemia |
| RS2086807269 |
PEX16
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS2086814554 |
PEX16
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS2086815766 |
PRKAR1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Carney complex |
| RS2086819893 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Tuberous sclerosis syndrome |
| RS2086819957 |
FANCD2
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group D2, Fanconi anemia complementation group D2 |
| RS2086826069 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2086840439 |
PCNT
|
Health Risk |
Likely pathogenic |
— |
| RS2086855300 |
DNAAF1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2086862509 |
FANCD2
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group D2, Fanconi anemia |
| RS2086865333 |
FANCD2
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group D2, Fanconi anemia complementation group D2 |
| RS2086865732 |
B2M
|
Health Risk |
Pathogenic |
Hypoproteinemia, hypercatabolic |
| RS2086865775 |
FANCD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group D2 |
| RS2086875746 |
FCHO1
|
Health Risk |
Pathogenic |
Severe congenital neutropenia, Immunodeficiency 76 |
| RS2086878882 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS2086880392 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Intellectual disability, Autistic behavior |
| RS2086887013 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2086888561 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2086892010 |
FANCD2
|
Health Risk |
Likely pathogenic |
— |
| RS2086917516 |
FANCD2
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2086918352 |
FANCD2
|
Health Risk |
Pathogenic/Likely pathogenic |
FANCD2-related disorder, Fanconi anemia |
| RS2086920799 |
FANCD2
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2086921262 |
FANCD2
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group D2, Fanconi anemia complementation group D2 |
| RS2086970259 |
DNAH17
|
Health Risk |
Likely pathogenic |
DNAH17-related disorder, DNAH17-related disorder |
| RS2086991061 |
KBTBD13
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 6, Nemaline myopathy 6 |
| RS2086993116 |
IDH3B
|
Health Risk |
Pathogenic |
— |
| RS2087004754 |
KBTBD13
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 6, Inborn genetic diseases |
| RS2087008432 |
PLA2G6
|
Health Risk |
Pathogenic |
Infantile neuroaxonal dystrophy, Infantile neuroaxonal dystrophy |
| RS2087013746 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2087026946 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2087028639 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS2087029320 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Global developmental delay, Global developmental delay |
| RS2087030906 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Intellectual disability |
| RS2087032456 |
TSC2
|
Health Risk |
Pathogenic |
Lymphangiomyomatosis, Lymphangiomyomatosis |
| RS2087033635 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2087036788 |
PCNT
|
Health Risk |
Pathogenic |
— |
| RS2087041072 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2087063244 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS2087073639 |
FANCD2
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group D2, Fanconi anemia complementation group D2 |
| RS2087101244 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy |
| RS2087109946 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2087125303 |
FANCD2
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group D2, Fanconi anemia complementation group D2 |
| RS2087129514 |
FANCD2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2087133817 |
FANCD2
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group D2, Fanconi anemia complementation group D2 |
| RS2087135251 |
PLA2G6
|
Health Risk |
Conflicting classifications of pathogenicity |
Infantile neuroaxonal dystrophy, Infantile neuroaxonal dystrophy |
| RS2087144643 |
LTBP2
|
Health Risk |
Likely pathogenic |
— |
| RS2087146072 |
PLA2G6
|
Health Risk |
Pathogenic |
Infantile neuroaxonal dystrophy, Infantile neuroaxonal dystrophy |
| RS2087167387 |
MYO18B
|
Health Risk |
Pathogenic/Likely pathogenic |
Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome, Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome |
| RS2087183662 |
PLA2G6
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2087184707 |
PLA2G6
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodegeneration with brain iron accumulation, Infantile neuroaxonal dystrophy |
| RS2087187562 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2087209471 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2087215071 |
CHAMP1
|
Health Risk |
Pathogenic |
— |
| RS2087224465 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS2087230045 |
CHAMP1
|
Health Risk |
Pathogenic |
— |
| RS2087230941 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2087233948 |
CHAMP1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Intellectual disability |
| RS2087240702 |
CHAMP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 40 |
| RS2087242404 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2087243806 |
CHAMP1
|
Health Risk |
Pathogenic |
— |
| RS2087247418 |
FANCD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Fanconi anemia |
| RS2087297703 |
IL21R
|
Health Risk |
Likely pathogenic |
Cryptosporidiosis-chronic cholangitis-liver disease syndrome, Cryptosporidiosis-chronic cholangitis-liver disease syndrome |
| RS2087377266 |
DLG3
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS2087391194 |
ZIC1
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2087395615 |
DNAAF1
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2087399510 |
ZIC1
|
Health Risk |
Likely pathogenic |
Craniosynostosis 6, Craniosynostosis 6 |
| RS2087444941 |
IL21R
|
Health Risk |
Conflicting classifications of pathogenicity |
Cryptosporidiosis-chronic cholangitis-liver disease syndrome, Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome |
| RS2087478227 |
PLA2G6
|
Health Risk |
Likely pathogenic |
Neurodegeneration with brain iron accumulation 2B, Neurodegeneration with brain iron accumulation 2B |
| RS2087482291 |
DYM
|
Health Risk |
Pathogenic/Likely pathogenic |
Dyggve-Melchior-Clausen syndrome, Dyggve-Melchior-Clausen syndrome |
| RS2087484070 |
GOSR2
|
Health Risk |
Pathogenic |
Progressive myoclonic epilepsy, Progressive myoclonic epilepsy |
| RS2087496511 |
DYM
|
Health Risk |
Pathogenic |
Dyggve-Melchior-Clausen syndrome, Dyggve-Melchior-Clausen syndrome |
| RS2087498329 |
DYM
|
Health Risk |
Pathogenic |
Dyggve-Melchior-Clausen syndrome, Dyggve-Melchior-Clausen syndrome |
| RS2087501886 |
DYM
|
Health Risk |
Likely pathogenic |
— |
| RS2087501902 |
TNFRSF13B
|
Health Risk |
Pathogenic |
Immunodeficiency, common variable |
| RS2087504321 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2087528394 |
TCN2
|
Health Risk |
Pathogenic |
Transcobalamin II deficiency, Transcobalamin II deficiency |
| RS2087532435 |
TCN2
|
Health Risk |
Pathogenic |
Transcobalamin II deficiency, Transcobalamin II deficiency |
| RS2087564577 |
TCN2
|
Health Risk |
Pathogenic |
Transcobalamin II deficiency, Transcobalamin II deficiency |
| RS2087565101 |
PCNT
|
Health Risk |
Pathogenic |
— |